{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:28:23Z","timestamp":1776796103998,"version":"3.51.2"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11940-019-0549-2","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T03:04:48Z","timestamp":1550718288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Comprehensive Management of Cerebellar Ataxia in Adults"],"prefix":"10.1007","volume":"21","author":[{"given":"Christopher D.","family":"Stephen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate T.","family":"Brizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Bouffard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Gomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey L.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D.","family":"Schmahmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"issue":"4","key":"549_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/brain\/121.4.561","volume":"121","author":"JD Schmahmann","year":"1998","unstructured":"Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(4):561\u201379.","journal-title":"Brain"},{"key":"549_CR2","doi-asserted-by":"crossref","unstructured":"Di Donato I, Bianchi S, Federico A. Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci. 2010 Aug;31(4):511\u20135.","DOI":"10.1007\/s10072-010-0261-1"},{"issue":"2","key":"549_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11065-012-9200-7","volume":"22","author":"ME Lough","year":"2012","unstructured":"Lough ME. Wernicke\u2019s encephalopathy: expanding the diagnostic toolbox. Neuropsychol Rev. 2012;22(2):181\u201394.","journal-title":"Neuropsychol Rev"},{"issue":"7","key":"549_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/WNL.56.7.849","volume":"56","author":"O Musumeci","year":"2001","unstructured":"Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki N, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology. 2001;56(7):849\u201355.","journal-title":"Neurology"},{"issue":"9","key":"549_CR5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/mds.23129","volume":"25","author":"M Pineda","year":"2010","unstructured":"Pineda M, Montero R, Aracil A, et al. Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up. Mov Disord. 2010;25(9):1262\u20138.","journal-title":"Mov Disord"},{"issue":"11","key":"549_CR6","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00415-014-7476-7","volume":"261","author":"A Balreira","year":"2014","unstructured":"Balreira A, Boczonadi V, Barca E, et al. ANO10 mutations cause ataxia and coenzyme Q10 deficiency. J Neurol. 2014;261(11):2192\u20138.","journal-title":"J Neurol"},{"key":"549_CR7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","volume":"90","author":"TA Zesiewicz","year":"2018","unstructured":"\u2022\u2022 Zesiewicz TA, Wilmot G, Kuo S-H, et al. Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia. Neurology. 2018;90:464\u201371 Comprehensive systematic review from the AAN on treatments and their evidence base in the ataxias.","journal-title":"Neurology"},{"key":"549_CR8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","volume":"74","author":"G Ristori","year":"2010","unstructured":"Ristori G, Romano S, Visconti A, et al. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010;74:839\u201345.","journal-title":"Neurology"},{"key":"549_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","volume":"14","author":"S Romano","year":"2015","unstructured":"\u2022\u2022 Romano S, Coarelli G, Marcotulli C, et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14:985\u201391 Seminal clinical trial demonstrating potential efficacy of riluzole in a mixed ataxia cohort.","journal-title":"Lancet Neurol"},{"key":"549_CR10","unstructured":"FDA Rilutek drug information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020599s011s012lbl.pdf . Accessed 2 Apr 2018."},{"key":"549_CR11","unstructured":"Trial of BHV-4157 (Troriluzole\/Trigriluzole) in Adult Subjects With Spinocerebellar Ataxia. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02960893 . Accessed 2 Apr 2018."},{"key":"549_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12311-013-0531-6","volume":"13","author":"W Ilg","year":"2014","unstructured":"\u2022 Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claa\u00dfen J, et al. Consensus paper: management of degenerative cerebellar disorders. Cerebellum. 2014;13:248\u201368. An excellent review on evidence on medical treatment, rehabilitation and future potential therapies in the management of degenerative ataxias.","journal-title":"Cerebellum"},{"key":"549_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","volume":"77","author":"M Strupp","year":"2011","unstructured":"Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77:269\u201375.","journal-title":"Neurology"},{"issue":"9","key":"549_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Uncini A. Yuki N; GBS classification group; GBS classification group. Guillain-Barr\u00e9 and miller fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014;10(9):537\u201344.","journal-title":"Nat Rev Neurol"},{"key":"549_CR15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u0144o","year":"2014","unstructured":"Ari\u0144o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies. Immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316.","journal-title":"JAMA Neurol"},{"key":"549_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000342217","volume":"69","author":"A Matsunaga","year":"2013","unstructured":"Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M. Hashimoto\u2019s encephalopathy as a treatable adultonset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol. 2013;69:14\u201320.","journal-title":"Eur Neurol"},{"key":"549_CR17","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(98)05342-2","volume":"352","author":"M Hadjivassiliou","year":"1998","unstructured":"Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582\u20135.","journal-title":"Lancet"},{"key":"549_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.","journal-title":"Lancet Neurol"},{"key":"549_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40673-017-0073-7","volume":"4","author":"H Mitoma","year":"2017","unstructured":"Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: from bench to bedside. Cerebellum Ataxias. 2017;4:16. https:\/\/doi.org\/10.1186\/s40673-017-0073-7 eCollection 2017.","journal-title":"Cerebellum Ataxias"},{"issue":"8","key":"549_CR20","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1212\/01.WNL.0000120752.24980.B3","volume":"62","author":"JD Schmahmann","year":"2004","unstructured":"Schmahmann JD. Plasmapheresis improves outcome in postinfectious cerebellitis induced by Epstein-Barr virus. Neurology. 2004;62(8):1443.","journal-title":"Neurology"},{"key":"549_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-444-51892-7.00013-9","volume":"103","author":"S Vernino","year":"2012","unstructured":"Vernino S. Paraneoplastic cerebellar degeneration. Handb Clin Neurol. 2012;103:215\u201323.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"549_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"\u2022 Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15(2):213\u201332 Excellent review on immune mediated ataxias.","journal-title":"Cerebellum"},{"issue":"11","key":"549_CR23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp.2006.088930","volume":"77","author":"SA Cooper","year":"2006","unstructured":"Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry. 2006;77(11):1273\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"549_CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/mds.23584","volume":"26","author":"J Gaalen van","year":"2011","unstructured":"\u2022\u2022 van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26(5):792\u2013800 Review paper on the presence of other movement disorders in the ataxias.","journal-title":"Mov Disord"},{"issue":"1","key":"549_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13311-013-0230-5","volume":"11","author":"SA Schneider","year":"2014","unstructured":"Schneider SA, Deuschl G. The treatment of tremor. Neurotherapeutics. 2014;11(1):128\u201338.","journal-title":"Neurotherapeutics"},{"key":"549_CR26","doi-asserted-by":"crossref","unstructured":"Hall DA, O'keefe JA. Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Tremor Other Hyperkinet Mov (N Y). 2012;2.","DOI":"10.5334\/tohm.112"},{"key":"549_CR27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00415-006-0112-4","volume":"253","author":"P Striano","year":"2006","unstructured":"Striano P, Coppola A, Vacca G, et al. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. J Neurol. 2006;253:762\u20136.","journal-title":"J Neurol"},{"key":"549_CR28","doi-asserted-by":"crossref","unstructured":"Niemann N, Jankovic J. Botulinum toxin for the treatment of hand tremor. Toxins (Basel). 2018;10(7).","DOI":"10.3390\/toxins10070299"},{"key":"549_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/pgmj.2003.015297","volume":"80","author":"R Nandagopal","year":"2004","unstructured":"Nandagopal R, Moorthy SG. Dramatic levodopa responsiveness of dystonia in a sporadic case of spinocerebellar ataxia type 3. Postgrad Med J. 2004;80:363\u20135.","journal-title":"Postgrad Med J"},{"key":"549_CR30","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/mds.22756","volume":"24","author":"M Kitahara","year":"2009","unstructured":"Kitahara M, Shimohata T, Tokunaga J, Nishizawa M. Cervical dystonia associated with spinocerebellar ataxia type 2 successfully treated with levodopa: a case report. Mov Disord. 2009;24:2163\u20134.","journal-title":"Mov Disord"},{"issue":"12","key":"549_CR31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.parkreldis.2015.10.016","volume":"21","author":"MB Nunes","year":"2015","unstructured":"Nunes MB, Martinez AR, Rezende TJ, et al. Dystonia in Machado-Joseph disease: clinical profile, therapy and anatomical basis. Parkinsonism Relat Disord. 2015;21(12):1441\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"549_CR32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s004150050465","volume":"246","author":"A Munchau","year":"1999","unstructured":"Munchau A, Dressler D, Bhatia KP, Vogel P, Zuhlke C. Machado-Joseph disease presenting as severe generalised dystonia in a German patient. J Neurol. 1999;246:840\u20132.","journal-title":"J Neurol"},{"key":"549_CR33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.1252","volume":"17","author":"KD Sethi","year":"2002","unstructured":"Sethi KD, Jankovic J. Dystonia in spinocerebellar ataxia type 6. Mov Disord. 2002;17:150\u20133.","journal-title":"Mov Disord"},{"key":"549_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(03)00129-1","volume":"213","author":"E Wilder-Smith","year":"2003","unstructured":"Wilder-Smith E, Tan EK, Law HY, Zhao Y, Ng I, Wong MC. Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family. J Neurol Sci. 2003;213:25\u20138.","journal-title":"J Neurol Sci"},{"issue":"7","key":"549_CR35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.25552","volume":"28","author":"J Jankovic","year":"2013","unstructured":"Jankovic J. Medical treatment of dystonia. Mov Disord. 2013;28(7):1001\u201312.","journal-title":"Mov Disord"},{"issue":"5","key":"549_CR36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mds.10708","volume":"19","author":"YR Wu","year":"2004","unstructured":"Wu YR, Lee-Chen GJ, Lang AE, Chen CM, Lin HY, Chen ST. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov Disord. 2004;19(5):586\u20137.","journal-title":"Mov Disord"},{"issue":"5","key":"549_CR37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1531-8257(200009)15:5<1028::AID-MDS1047>3.0.CO;2-#","volume":"15","author":"F Cardoso","year":"2000","unstructured":"Cardoso F, de Oliveira JT, Puccioni-Sohler M, Fernandes AR, de Mattos JP, Lopes-Cendes I. Eyelid dystonia in Machado-Joseph disease. Mov Disord. 2000;15(5):1028\u201330.","journal-title":"Mov Disord"},{"issue":"5","key":"549_CR38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.20442","volume":"20","author":"W Freeman","year":"2005","unstructured":"Freeman W, Wszolek Z. Botulinum toxin type A for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease). Mov Disord. 2005;20(5):644.","journal-title":"Mov Disord"},{"key":"549_CR39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/mds.10243","volume":"17","author":"CS Lu","year":"2002","unstructured":"Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord. 2002;17:1046\u201351.","journal-title":"Mov Disord"},{"key":"549_CR40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.10322","volume":"18","author":"C Buhmann","year":"2003","unstructured":"Buhmann C, Bussopulos A, Oechsner M. Dopaminergic response in parkinsonian phenotype of Machado-Joseph disease. Mov Disord. 2003;18:219\u201321.","journal-title":"Mov Disord"},{"key":"549_CR41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mds.20090","volume":"19","author":"J Infante","year":"2004","unstructured":"Infante J, Berciano J, Volpini V, et al. Spinocerebellar ataxia type 2 with levodopa-responsive parkinsonism culminating in motor neuron disease. Mov Disord. 2004;19:848\u201352.","journal-title":"Mov Disord"},{"key":"549_CR42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/mds.10715","volume":"19","author":"A Wilkins","year":"2004","unstructured":"Wilkins A, Brown JM, Barker RA. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report. Mov Disord. 2004;19:593\u20135.","journal-title":"Mov Disord"},{"key":"549_CR43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.55.6.800","volume":"55","author":"K Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology. 2000;55:800\u20135.","journal-title":"Neurology"},{"issue":"4","key":"549_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285610375328","volume":"3","author":"O Flabeau","year":"2010","unstructured":"\u2022 Flabeau O, Meissner WG, Tison F. Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord. 2010;3(4):249\u201363 Excellent review paper on the management of MSA.","journal-title":"Ther Adv Neurol Disord"},{"key":"549_CR45","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Artusi CA, Farooqi A, Romagnolo A, et al. Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming. J Neurol. 2018. https:\/\/doi.org\/10.1007\/s00415-018-8823-x Excellent review of DBS in uncommon tremor disorders including the ataxias.","DOI":"10.1007\/s00415-018-8823-x"},{"key":"549_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22354","volume":"24","author":"JM Ferrara","year":"2009","unstructured":"Ferrara JM, Adam OR, Ondo WG. Treatment of fragile-X associated tremor\/ataxia syndrome with deep brain stimulation. Mov Disord. 2009;24:149\u201351.","journal-title":"Mov Disord"},{"key":"549_CR47","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/mds.24923","volume":"27","author":"S Senova","year":"2012","unstructured":"Senova S, Jarraya B, Iwamuro H, et al. Unilateral thalamic stimulation safely improved fragile X-associated tremor ataxia: a case report. Mov Disord. 2012;27:797\u20139.","journal-title":"Mov Disord"},{"key":"549_CR48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mds.24958","volume":"27","author":"T Xie","year":"2012","unstructured":"Xie T, Goodman R, Browner N, et al. Treatment of fragile X-associated tremor\/ataxia syndrome with unilateral deep brain stimulation. Mov Disord. 2012;27:799\u2013800.","journal-title":"Mov Disord"},{"key":"549_CR49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12311-013-0530-7","volume":"13","author":"R Mehanna","year":"2014","unstructured":"Mehanna R, Itin I. Which approach is better: bilateral versus unilateral thalamic deep brain stimulation in patients with fragile X-associated tremor ataxia syndrome. Cerebellum. 2014;13:222\u20135.","journal-title":"Cerebellum"},{"key":"549_CR50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.parkreldis.2014.12.015","volume":"21","author":"D Weiss","year":"2015","unstructured":"Weiss D, Mielke C, W\u00e4chter T, et al. Long-term outcome of deep brain stimulation in fragile X-associated tremor\/ataxia syndrome. Parkinsonism Relat Disord. 2015;21:310\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"549_CR51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pjnns.2016.04.004","volume":"50","author":"G Tam\u00e1s","year":"2016","unstructured":"Tam\u00e1s G, Kov\u00e1cs N, Varga N\u00c1, et al. Deep brain stimulation or thalamotomy in fragile X-associated tremor\/ataxia syndrome? Case report. Neurol Neurochir Pol. 2016;50:303\u20138.","journal-title":"Neurol Neurochir Pol"},{"key":"549_CR52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1212\/WNL.0000000000001553","volume":"84","author":"MG Santos Ghilardi dos","year":"2015","unstructured":"dos Santos Ghilardi MG, Cury RG, dos \u00c2ngelos JS, et al. Long-term improvement of tremor and ataxia after bilateral DBS of VoP\/zona incerta in FXTAS. Neurology. 2015;84:1904\u20136.","journal-title":"Neurology"},{"key":"549_CR53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/ner.12150","volume":"17","author":"G Oyama","year":"2014","unstructured":"Oyama G, Umemura A, Shimo Y, et al. Posterior subthalamic area deep brain stimulation for fragile X-associated tremor\/ataxia syndrome. Neuromodulation. 2014;17:721\u20133.","journal-title":"Neuromodulation"},{"key":"549_CR54","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Oyama G, Thompson A, Foote KD, Limotai N, Abd-El-Barr M, Maling N, Malaty IA, Rodriguez RL, Subramony SH, Ashizawa T, Okun MS. Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y). 2014;4:228. https:\/\/doi.org\/10.7916\/D8542KQ5 . eCollection 2014. Paper on DBS in ataxias and the comparison to essential tremor.","DOI":"10.7916\/D8542KQ5"},{"key":"549_CR55","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mds.21338","volume":"22","author":"HJ Freund","year":"2007","unstructured":"Freund HJ, Barnikol UB, Nolte D, et al. Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor\u2014a unusual clinical benefit. Mov Disord. 2007;22:732\u20135.","journal-title":"Mov Disord"},{"issue":"1","key":"549_CR56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/acn3.508","volume":"5","author":"T Hashimoto","year":"2017","unstructured":"Hashimoto T, Muralidharan A, Yoshida K, et al. Neuronal activity and outcomes from thalamic surgery for spinocerebellar ataxia. Ann Clin Transl Neurol. 2017;5(1):52\u201363.","journal-title":"Ann Clin Transl Neurol"},{"key":"549_CR57","doi-asserted-by":"crossref","first-page":"2075e6","DOI":"10.1212\/WNL.0000000000002204","volume":"85","author":"MJ Teixeira","year":"2015","unstructured":"Teixeira MJ, Cury RG, Galhardoni R, Barboza VR, Brunoni AR, Alho E, et al. Deep brain stimulation of the dentate nucleus improves cerebellar ataxia after cerebellar stroke. Neurology. 2015;85:2075e6.","journal-title":"Neurology"},{"issue":"9","key":"549_CR58","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2011-301714","volume":"84","author":"M Vidailhet","year":"2013","unstructured":"Vidailhet M, Jutras MF, Grabli D, Roze E. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry. 2013;84(9):1029\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"549_CR59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ner.12081","volume":"17","author":"BJ Copeland","year":"2014","unstructured":"Copeland BJ, Fenoy A, Ellmore TM, Liang Q, Ephron V, Schiess M. Deep brain stimulation of the internal globus pallidus for generalized dystonia associated with spinocerebellar ataxia type 1: a case report. Neuromodulation. 2014;17(4):389\u201392.","journal-title":"Neuromodulation"},{"issue":"4","key":"549_CR60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000345265","volume":"91","author":"AM Harries","year":"2013","unstructured":"Harries AM, Sandhu M, Spacey SD, Aly MM, Honey CR. Unilateral pallidal deep brain stimulation in a patient with dystonia secondary to episodic ataxia type 2. Stereotact Funct Neurosurg. 2013;91(4):233\u20135.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"549_CR61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.brs.2017.11.015","volume":"11","author":"C Fran\u00e7a","year":"2018","unstructured":"Fran\u00e7a C, de Andrade DC, Teixeira MJ, et al. Effects of cerebellar neuromodulation in movement disorders: a systematic review. Brain Stimul. 2018;11(2):249\u201360.","journal-title":"Brain Stimul"},{"key":"549_CR62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jnnp.72.1.124","volume":"72","author":"Y Shiga","year":"2002","unstructured":"Shiga Y, Tsuda T, Itoyama Y, et al. Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry. 2002;72:124\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"549_CR63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CIA.S1794","volume":"3","author":"RJ Hagerman","year":"2008","unstructured":"\u2022 Hagerman RJ, Hall DA, Coffey S, et al. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging. 2008;3(2):251\u201362 Excellent review paper on the treatment of Fragile X Tremor Ataxia Syndrome.","journal-title":"Clin Interv Aging"},{"issue":"Pt 3","key":"549_CR64","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/brain\/awl376","volume":"130","author":"W Ilg","year":"2007","unstructured":"Ilg W, Golla H, Thier P, Giese MA. Specific influences of cerebellar dysfunctions on gait. Brain. 2007;130(Pt 3):786\u201398.","journal-title":"Brain"},{"issue":"Pt 7","key":"549_CR65","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/122.7.1349","volume":"122","author":"G Ebersbach","year":"1999","unstructured":"Ebersbach G, Sojer M, Valldeoriola F, et al. Comparative analysis of gait in Parkinson\u2019s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain. 1999;122(Pt 7):1349\u201355.","journal-title":"Brain"},{"issue":"1","key":"549_CR66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000342907","volume":"69","author":"EM Fonteyn","year":"2013","unstructured":"Fonteyn EM, Schmitz-H\u00fcbsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, et al. Prospective analysis of falls in dominant ataxias. Eur Neurol. 2013;69(1):53\u20137.","journal-title":"Eur Neurol"},{"key":"549_CR67","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0b013e3181c33adf","volume":"73","author":"W Ilg","year":"2009","unstructured":"\u2022 Ilg W, Synofzik M, Brotz D, Burkard S, Giese MA, Schols L. Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology. 2009;73:1823\u201330 Paper on outpatient PT in ataxia.","journal-title":"Neurology"},{"key":"549_CR68","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/mds.23222","volume":"25","author":"W Ilg","year":"2010","unstructured":"Ilg W, Brotz D, Burkard S, Giese MA, Schols L, Synofzik M. Long-term effects of coordinative training in degenerative cerebellar disease. Mov Disord. 2010;25:2239\u201346.","journal-title":"Mov Disord"},{"key":"549_CR69","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1545968311425918","volume":"265","author":"I Miyai","year":"2012","unstructured":"\u2022 Miyai I, Ito M, Hattori N, et al. Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair. 2012;265:515\u201322 Paper on an intensive inpatient treatment program for ataxia.","journal-title":"Neurorehabil Neural Repair"},{"issue":"3","key":"549_CR70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/NPT.0b013e318185558f","volume":"32","author":"C Gibson-Horn","year":"2008","unstructured":"Gibson-Horn C. Balance-based torso-weighting in a patient with ataxia and multiple sclerosis: a case report. J Neurol Phys Ther. 2008;32(3):139\u201346.","journal-title":"J Neurol Phys Ther"},{"issue":"6","key":"549_CR71","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1590\/S0100-879X2010005000009","volume":"43","author":"RC Silva","year":"2010","unstructured":"Silva RC, Saute JA, Silva AC, Coutinho AC, Saraiva-Pereira ML, Jardim LB. Occupational therapy in spinocerebellar ataxia type 3: an open-label trial. Braz J Med Biol Res. 2010;43(6):537\u201342.","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"549_CR72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0269215510382495","volume":"25","author":"J Marsden","year":"2011","unstructured":"\u2022 Marsden J, Harris C. Cerebellar ataxia: pathophysiology and rehabilitation. Clin Rehabil. 2011;25(3):195\u2013216 Review paper on rehabilitation in ataxia.","journal-title":"Clin Rehabil"},{"issue":"1","key":"549_CR73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5014\/ajot.54.1.89","volume":"54","author":"G Gillen","year":"2000","unstructured":"\u2022\u2022 Gillen G. Improving activities of daily living performance in an adult with ataxia. Am J Occup Ther. 2000;54(1):89\u201396 Excellent, practical review on OT for ataxia, which is very useful for occupational therapists treating ataxia patients.","journal-title":"Am J Occup Ther"},{"issue":"3","key":"549_CR74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0141-5425(90)90043-M","volume":"12","author":"MJ Broadhurst","year":"1990","unstructured":"Broadhurst MJ, Stammers CW. Mechanical feeding aids for patients with ataxia: design considerations. J Biomed Eng. 1990;12(3):209\u201314.","journal-title":"J Biomed Eng"},{"issue":"11","key":"549_CR75","first-page":"332","volume":"61","author":"MH Morgan","year":"1975","unstructured":"Morgan MH. Ataxia and weights. Physiotherapy. 1975;61(11):332\u20134.","journal-title":"Physiotherapy"},{"key":"549_CR76","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.43.7.1346","volume":"43","author":"ML Aisen","year":"1993","unstructured":"Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M. The effect of mechanical damping loads on disabling action tremor. Neurology. 1993;43:1346\u201350.","journal-title":"Neurology"},{"key":"549_CR77","first-page":"235","volume":"38","author":"P Feys","year":"2001","unstructured":"Feys P, Romberg A, Ruutiainen J, et al. Assistive technology to improve PC interaction for people with intention tremor. J Rehabil Res Dev. 2001;38:235\u201343.","journal-title":"J Rehabil Res Dev"},{"key":"549_CR78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijmedinf.2005.07.042","volume":"75","author":"T Surdilovic","year":"2006","unstructured":"Surdilovic T, Zhang YQ. Convenient intelligent cursor control web systems for Internet users with severe motor-impairments. Int J Med Inform. 2006;75:86\u2013100.","journal-title":"Int J Med Inform"},{"issue":"9","key":"549_CR79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5014\/ajot.44.9.797","volume":"44","author":"R Lysaght","year":"1990","unstructured":"Lysaght R, Bodenhamer E. The use of relaxation training to enhance functional outcomes in adults with traumatic head injuries. Am J Occup Ther. 1990;44(9):797\u2013802.","journal-title":"Am J Occup Ther"},{"issue":"4","key":"549_CR80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/02701960802497894","volume":"29","author":"MG O'Connor","year":"2008","unstructured":"\u2022 O'Connor MG, Kapust LR, Hollis AM. DriveWise: an interdisciplinary hospital-based driving assessment program. Gerontol Geriatr Educ. 2008;29(4):351\u201362 Review on a driving program in dementia and other degenerative disorders.","journal-title":"Gerontol Geriatr Educ"},{"issue":"3","key":"549_CR81","first-page":"143","volume":"38","author":"KS Erler","year":"2018","unstructured":"Erler KS, Juengst SB, Smith DL, et al. Examining driving and participation 5 years after traumatic brain injury. OTJR (Thorofare N J). 2018;38(3):143\u201350.","journal-title":"OTJR (Thorofare N J)"},{"key":"549_CR82","doi-asserted-by":"crossref","unstructured":"\u2022 Kent RD, Kent JF, Duffy JR, Thomas JE, Weismer G, Stuntebeck, S: Ataxic dysarthria. J Speech Lang Hear Res. 2000;43(5):1275-1289. A good overview of ataxic dysarthria.","DOI":"10.1044\/jslhr.4305.1275"},{"issue":"4","key":"549_CR83","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1044\/jshd.4604.398","volume":"46","author":"KM Yorkston","year":"1981","unstructured":"Yorkston KM, Beukelman DR. Ataxic dysarthria: treatment sequences based on intelligibility and prosodic considerations. J Speech Hear Disord. 1981;46(4):398\u2013404.","journal-title":"J Speech Hear Disord"},{"issue":"3","key":"549_CR84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1044\/1058-0360(2008\/025)","volume":"17","author":"E Maas","year":"2008","unstructured":"Maas E, Robin DA, Austermann Hula SN, Freedman SE, Wulf G, Ballard KJ, et al. Principles of motor learning in treatment of motor speech disorders. Am J Speech Lang Pathol. 2008;17(3):277\u201398.","journal-title":"Am J Speech Lang Pathol"},{"key":"549_CR85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1044\/leader.FTR1.22032017.44","volume":"22","author":"JC Rosenbeck","year":"2017","unstructured":"Rosenbeck JC. Mind over Motor. ASHA Lead. 2017;22:44\u20139.","journal-title":"ASHA Lead"},{"key":"549_CR86","first-page":"CD008953","volume":"10","author":"AP Vogel","year":"2014","unstructured":"\u2022 Vogel AP, Folker J, Poole ML. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database Syst Rev. 2014;10:CD008953 Cochrane Review on treatment of speech disorder in the ataxias.","journal-title":"Cochrane Database Syst Rev"},{"key":"549_CR87","first-page":"CD010169","volume":"11","author":"AP Vogel","year":"2015","unstructured":"\u2022 Vogel AP, Keage MJ, Johansson K, Schalling E. Treatment for dysphagia (swallowing difficulties) in hereditary ataxia (review). Cochrane Database Syst Rev. 2015;11:CD010169 Cochrane Review on the treatment of dysphagia in the ataxias.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt A","key":"549_CR88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.toxicon.2015.08.014","volume":"107","author":"M Petracca","year":"2015","unstructured":"Petracca M, Guidubaldi A, Ricciardi L, Ialongo T, Del Grande A, Mulas D, et al. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview. Toxicon. 2015;107(Pt A):129\u201340.","journal-title":"Toxicon"},{"key":"549_CR89","unstructured":"\u2022 Leigh JR, Zee DS (1999) The Neurology of Eye Movements, 3rd edn. Oxford University Press, New York, p 223\u2013228, 238. Excellent resource on the neurology of eye movements."},{"key":"549_CR90","unstructured":"Leigh JR, Zee DS. The neurology of eye movements. 3rd ed. New York: Oxford University Press; 1999. p. 104\u20138. 310-327, 367-375, 406-416"},{"key":"549_CR91","first-page":"535","volume-title":"The neurology of eye movements","author":"JR Leigh","year":"1999","unstructured":"Leigh JR, Zee DS. The neurology of eye movements. 3rd ed. New York: Oxford University Press; 1999. p. 535\u201342.","edition":"3"},{"issue":"4","key":"549_CR92","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1364\/JOSA.58.000562","volume":"58","author":"FC Volkmann","year":"1968","unstructured":"Volkmann FC, Schick AML, Riggs LA. Time course of visual inhibition during voluntary saccades. J Opt Soc Am. 1968;58(4):562\u20139.","journal-title":"J Opt Soc Am"},{"key":"549_CR93","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awh532","volume":"128","author":"C Pierrot-Deseilligny","year":"2005","unstructured":"Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain. 2005;128:1237\u201346.","journal-title":"Brain"},{"key":"549_CR94","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.2004.045716","volume":"76","author":"S Glasauer","year":"2005","unstructured":"Glasauer S, Kalla R. Buttner U, et al. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry. 2005;76:451\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"549_CR95","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/01.WNL.0000118287.68294.E5","volume":"62","author":"R Kalla","year":"2004","unstructured":"Kalla R, Glasauer S. Schautzer F, et al. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology. 2004;62:1228\u20139.","journal-title":"Neurology"},{"issue":"2","key":"549_CR96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","volume":"61","author":"M Strupp","year":"2003","unstructured":"Strupp M, Schuler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine \u2013 a placebo-controlled study. Neurology. 2003;61(2):165\u201370.","journal-title":"Neurology"},{"issue":"7","key":"549_CR97","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0161-6420(86)33640-6","volume":"93","author":"JN Currie","year":"1986","unstructured":"Currie JN, Matsuo V. The use of clonazepam in the treatment of nystagmus-induced oscillopsia. Ophthalmology. 1986;93(7):924.","journal-title":"Ophthalmology"},{"key":"549_CR98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","volume":"54","author":"M Dieterich","year":"1991","unstructured":"Dieterich M, Straube A, Brandt T, et al. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry. 1991;54:627\u201332.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"549_CR99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.3871968","volume":"228","author":"W Waespe","year":"1985","unstructured":"Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibulo-ocular reflex by the nodulus and uvula. Science. 1985;228:199\u2013202.","journal-title":"Science"},{"key":"549_CR100","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/01.wnl.0000257111.24769.d2","volume":"68","author":"HS Jeong","year":"2007","unstructured":"Jeong HS, Oh JY, Kim JS, et al. Periodic alternating nystagmus in isolated nodular infarction. Neurology. 2007;68:956\u20137.","journal-title":"Neurology"},{"key":"549_CR101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410080611","volume":"8","author":"GM Halmagyi","year":"1980","unstructured":"Halmagyi GM, Rudge P, Gresty MA, et al. Treatment of periodic alternating nystagmus. Ann Neurol. 1980;8:609\u201311.","journal-title":"Ann Neurol"},{"issue":"5","key":"549_CR102","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/WNL.30.5.471","volume":"30","author":"AH Koeppen","year":"1980","unstructured":"Koeppen AH, Barron KD, Dentinger MP. Olivary hypertrophy: histochemical demonstration of hydrolytic enzymes. Neurology. 1980;30(5):471.","journal-title":"Neurology"},{"issue":"1","key":"549_CR103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1749-6632.2011.06118.x","volume":"1233","author":"AG Shaikh","year":"2011","unstructured":"Shaikh AG, Thurtell MJ, Optican LM, et al. Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann N Y Acad Sci. 2011;1233(1):320\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"549_CR104","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","volume":"35","author":"L Zhang","year":"2017","unstructured":"\u2022 Zhang L, Cao B, Ou R, et al. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord. 2017;35:63\u20138 Good resource on non-motor symptoms in MSA.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"549_CR105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1590\/S1677-5538.IBJU.2013.06.14","volume":"39","author":"AF Musegante","year":"2013","unstructured":"Musegante AF, Almeida PN, Monteiro RT, Barroso U Jr. Urinary symptoms and urodynamics findings in patients with Friedreich\u2019s ataxia. Int Braz J Urol. 2013;39(6):867\u201374.","journal-title":"Int Braz J Urol"},{"issue":"1","key":"549_CR106","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13023-017-0709-y","volume":"12","author":"M Lad","year":"2017","unstructured":"\u2022 Lad M, Parkinson MH, Rai M. Urinary, bowel and sexual symptoms in a cohort of patients with Friedreich\u2019s ataxia. Orphanet J Rare Dis. 2017;12(1):158 Excellent paper on non-motor symptoms in Friedreich\u2019s ataxia.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"549_CR107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12311-015-0728-y","volume":"15","author":"DJ Lin","year":"2016","unstructured":"Lin DJ, Hermann KL, Schmahmann JD. The diagnosis and natural history of multiple system atrophy, Cerebellar Type. Cerebellum. 2016;15(6):663\u201379.","journal-title":"Cerebellum"},{"key":"549_CR108","doi-asserted-by":"publisher","unstructured":"Bassotti G, Usai-Satta P, Bellini M. Linaclotide for the treatment of chronic constipation. Expert Opin Pharmacother. 2018 Jul;9:1\u20136. https:\/\/doi.org\/10.1080\/14656566.2018.1494728 .","DOI":"10.1080\/14656566.2018.1494728"},{"key":"549_CR109","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","volume":"71","author":"IF Hussain","year":"2001","unstructured":"Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson\u2019s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2001;71:371\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"549_CR110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69\u201372.","journal-title":"Clin Auton Res"},{"issue":"3","key":"549_CR111","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018;33(3):372\u201390.","journal-title":"Mov Disord"},{"issue":"4","key":"549_CR112","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","volume":"63","author":"W Singer","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513\u20138.","journal-title":"Arch Neurol"},{"key":"549_CR113","doi-asserted-by":"publisher","unstructured":"Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018. https:\/\/doi.org\/10.1212\/WNL.0000000000005994 .","DOI":"10.1212\/WNL.0000000000005994"},{"key":"549_CR114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2015.11.021","volume":"22","author":"RY Lo","year":"2016","unstructured":"\u2022 Lo RY, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez C, et al. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016;22:87\u201392 Paper detailing depression in the SCAs.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"549_CR115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ane.12804","volume":"137","author":"LY Zhang","year":"2018","unstructured":"Zhang LY, Cao B, Zou YT, Wei QQ, Ou RW, Zhao B, et al. Depression and anxiety in multiple system atrophy. Acta Neurol Scand. 2018;137(1):33\u20137.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"549_CR116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mdc3.12382","volume":"4","author":"L Almeida","year":"2017","unstructured":"Almeida L, Ahmed B, Walz R, De Jesus S, Patterson A, Martinez-Ramirez D, et al. Depressive symptoms are frequent in atypical parkinsonian disorders. Mov Disord Clin Pract. 2017;4(2):191\u20137.","journal-title":"Mov Disord Clin Pract"},{"issue":"12","key":"549_CR117","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jagp.2015.07.007","volume":"23","author":"A Str\u00f6hle","year":"2015","unstructured":"Str\u00f6hle A, Schmidt DK, Schultz F, Fricke N, Staden T, Hellweg R, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry. 2015;23(12):1234\u201349.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"549_CR118","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1107911","volume":"366","author":"F Li","year":"2012","unstructured":"\u2022 Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson\u2019s disease. N Engl J Med. 2012;366(6):511\u20139. Important paper on the benefits of exercise in Parkinson\u2019s disease, with relevance to other degenerative movement disorders.","journal-title":"N Engl J Med"},{"issue":"2","key":"549_CR119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with De novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2018;75(2):219\u201326.","journal-title":"JAMA Neurol"},{"issue":"2","key":"549_CR120","first-page":"131","volume":"36","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wang F, Shi Y, Wang J, Xie Q. [Plum-blossom needle tapping at Jiaji (EX-B 2) combined with rehabilitation for ataxia of cerebellar apoplexy: a randomized controlled trial]. Zhongguo Zhen Jiu. 2016;36(2):131\u20134.","journal-title":"Zhongguo Zhen Jiu"},{"key":"549_CR121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.10.013","volume":"34","author":"L Wiblin","year":"2017","unstructured":"\u2022\u2022 Wiblin L, Lee M, Burn D. Palliative care and its emerging role in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord. 2017;34:7\u201314 Excellent paper on palliative care in atypical parkinsonism.","journal-title":"Parkinsonism Relat Disord"},{"key":"549_CR122","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMp1215620","volume":"368","author":"TE Quill","year":"2013","unstructured":"Quill TE, Abernethy AP. Generalist plus specialist palliative care- creating a more sustainable model. N Engl J Med. 2013;368:1173\u20135.","journal-title":"N Engl J Med"},{"issue":"12","key":"549_CR123","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1001\/jamainternmed.2014.5271","volume":"174","author":"RE Bernacki","year":"2014","unstructured":"Bernacki RE, Block SD, American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994\u20132003.","journal-title":"JAMA Intern Med"},{"issue":"14","key":"549_CR124","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","volume":"300","author":"AA Wright","year":"2008","unstructured":"Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665\u201373.","journal-title":"JAMA"},{"key":"549_CR125","doi-asserted-by":"crossref","unstructured":"Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006;333(7574).","DOI":"10.1136\/bmj.333.7574.0-b"},{"key":"549_CR126","doi-asserted-by":"crossref","first-page":"c1345","DOI":"10.1136\/bmj.c1345","volume":"340","author":"KM Detering","year":"2010","unstructured":"Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.","journal-title":"BMJ"},{"issue":"3","key":"549_CR127","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1017\/cjn.2016.439","volume":"44","author":"AM Dayal","year":"2017","unstructured":"Dayal AM, Jenkins ME, Jog MS, Kimpinski K, MacDonald P, Gofton TE. Palliative care discussions in multiple system atrophy: a retrospective review. Can J Neurol Sci. 2017;44(3):276\u201382.","journal-title":"Can J Neurol Sci"},{"issue":"1\u20132","key":"549_CR128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.09.022","volume":"276","author":"M Miyashita","year":"2009","unstructured":"Miyashita M, Narita Y, Sakamoto A, Kawada N, Akiyama M, Kayama M, et al. Care burden and depression in caregivers caring for patients with intractable neurologic disease at home in Japan. J Neurol Sci. 2009;276(1\u20132):148\u201352.","journal-title":"J Neurol Sci"},{"issue":"23","key":"549_CR129","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.282.23.2215","volume":"282","author":"R Schulz","year":"1999","unstructured":"Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA. 1999;282(23):2215\u20139.","journal-title":"JAMA"},{"issue":"4 Movement Diso","key":"549_CR130","first-page":"1104","volume":"22","author":"JM Miyasaki","year":"2016","unstructured":"Miyasaki JM. Treatment of advanced Parkinson disease and related disorders. Continuum. 2016;22(4 Movement Disorders):1104\u201316.","journal-title":"Continuum"},{"issue":"4","key":"549_CR131","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, et al. Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology. 2015;35(4):354\u201389.","journal-title":"Neuropathology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-019-0549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-019-0549-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-019-0549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T07:36:03Z","timestamp":1606548963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-019-0549-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s11940-019-0549-2","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"21 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kate Brizzi, Marc Bouffard, Pablo Gomery, Stacey Sullivan, Julie Mello, and Julie MacLean declare no potential conflicts of interest. Jeremy Schmahmann reports personal fees from Bayer, personal fees from Biogen, personal fees from Biohaven, personal fees from Cadent, personal fees from Pfizer, outside the submitted work; in addition, Dr. Schmahmann has a Brief Ataxia Rating Scale licensed to Schmahmann and the General Hospital Corporation, a Cerebellar Neuropsychiatric Rating Scale pending to Schmahmann and the General Hospital Corporation, and a Cerebellar Cognitive Affective syndrome\/Schmahmann Scale pending to Schmahmann and the General Hospital Corporation, and Royalties from Elsevier, MacKeith, Oxford, Springer; Grants from National Ataxia Foundation, Ataxia-Telangiectasia Children\u2019s Project, MINDlink Foundation. Christopher D. Stephen has been paid for work as an investigator as part of a multi-center US trial of troriluzole in the ataxias.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"9"}}